We are live on ! Find out more
STOK icon

Stoke Therapeutics
STOK

53 hedge funds and large institutions have $339M invested in Stoke Therapeutics in 2019 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 9

32% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 19

13% more funds holding

Funds holding: 47 → 53 (+6)

3.46% more ownership

Funds ownership: 45.24% → 48.7% (+3.5%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

17% less capital invested

Capital invested by funds: $409M → $339M (-$70.4M)

Holders
53
Holders Change
+6
Holders Change %
+12.77%
% of All Funds
1.16%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
25
Increased
13
Reduced
9
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$20.8M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$16M
3
BlackRock
BlackRock
New York
+$16M
4
Federated Hermes
Federated Hermes
Pennsylvania
+$12.9M
5
Millennium Management
Millennium Management
New York
+$4.05M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$7.29M
2
AI
Atom Investors
Texas
-$5.82M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.77M
4
O
OrbiMed
New York
-$3.79M
5
Citadel Advisors
Citadel Advisors
Florida
-$2.91M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$529K +$686K +24,595 New
N
27
Nuveen
North Carolina
$503K +$653K +23,399 New
Squarepoint
28
Squarepoint
New York
$466K +$605K +21,699 New
TD Asset Management
29
TD Asset Management
Ontario, Canada
$427K +$554K +19,879 New
GPCM
30
Granite Point Capital Management
Massachusetts
$365K -$474K -17,000 -50%
BIM
31
Bogle Investment Management
Massachusetts
$362K +$470K +16,849 New
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$307K +$398K +14,264 New
AC
33
Athanor Capital
New York
$305K +$396K +14,200 New
State of Wisconsin Investment Board
34
State of Wisconsin Investment Board
Wisconsin
$299K +$388K +13,900 New
FAM
35
Fred Alger Management
New York
$258K +$195K +7,000 +140%
New York State Common Retirement Fund
36
New York State Common Retirement Fund
New York
$206K +$268K +9,600 New
UBS Group
37
UBS Group
Switzerland
$131K +$127K +4,554 +300%
Morgan Stanley
38
Morgan Stanley
New York
$130K +$69.4K +2,490 +70%
Barclays
39
Barclays
United Kingdom
$129K +$142K +5,087 +557%
AIG
40
American International Group
New York
$124K +$161K +5,780 New
Victory Capital Management
41
Victory Capital Management
Texas
$84K +$39.4K +1,413 +57%
Bank of America
42
Bank of America
North Carolina
$79K +$104K +3,714 New
Wells Fargo
43
Wells Fargo
California
$74K +$96K +3,441 New
JP Morgan Chase
44
JP Morgan Chase
New York
$64K +$83.7K +3,001 New
Deutsche Bank
45
Deutsche Bank
Germany
$59K +$78.8K +2,825 New
SO
46
STRS Ohio
Ohio
$51K +$66.9K +2,400 New
Legal & General Group
47
Legal & General Group
United Kingdom
$32K +$41.5K +1,490 New
BNP Paribas Financial Markets
48
BNP Paribas Financial Markets
France
$24.9K +$32.3K +1,158 New
PIM
49
Platinum Investment Management
Australia
$21K – – –
AIP
50
Ameritas Investment Partners
Nebraska
$16K +$21.2K +761 New
1
2
3

STOK Hedge Fund Activity: Q3 2019 in Review

53 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Stoke Therapeutics (STOK) for Q3 2019, worth a combined $339M — down 17% from $409M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new STOK positions and 19 closed out — a net gain of 6 holders — while 13 added to existing stakes and 9 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $20.8M. The largest seller was Wellington Management Group, cutting an estimated $7.29M.

  • 53 institutional investors held Stoke Therapeutics (STOK) as of Q3 2019, up from 47 in Q2 2019.
  • Funds reported $339M of Stoke Therapeutics stock for Q3 2019, down 17% quarter-over-quarter.
  • 25 funds opened new Stoke Therapeutics positions in Q3 2019 and 19 closed out, a net change of +6 holders.
  • The largest Stoke Therapeutics buyer in Q3 2019 was Janus Henderson Group, an estimated $20.8M added.
  • The largest Stoke Therapeutics seller in Q3 2019 was Wellington Management Group, an estimated $7.29M sold.

Based on aggregated 13F filings for Q3 2019.